Delcath Systems (DCTH) Cash & Equivalents Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Delcath Systems | 383.27 Mn | 293.95 Mn | 21.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.20% |
| Dec 31, 2025 | 8.74% |
| Sep 30, 2025 | 196.98% |
| Jun 30, 2025 | 185.65% |
| Mar 31, 2025 | 134.28% |
| Dec 31, 2024 | 26.51% |
| Sep 30, 2024 | 115.00% |
| Mar 31, 2024 | -45.73% |
| Dec 31, 2023 | -45.73% |
| Sep 30, 2023 | 35.33% |
| Jun 30, 2023 | -45.73% |
| Mar 31, 2023 | -45.98% |
| Dec 31, 2022 | 0.75% |
| Sep 30, 2022 | 3.29% |
| Jun 30, 2022 | -20.24% |
| Mar 31, 2022 | 20.60% |
| Dec 31, 2021 | 38.91% |
| Sep 30, 2021 | 2.39% |
| Jun 30, 2021 | 60.35% |
| Mar 31, 2021 | 22.75% |
| Dec 31, 2020 | 17.78% |
| Sep 30, 2020 | -59.53% |
| Jun 30, 2020 | -58.12% |
| Mar 31, 2020 | -60.35% |
| Dec 31, 2019 | -13.34% |
| Sep 30, 2019 | -62.16% |
| Jun 30, 2019 | -58.11% |
| Mar 31, 2019 | -49.16% |
| Dec 31, 2018 | -49.15% |
| Sep 30, 2018 | -20.31% |
| Jun 30, 2018 | -49.50% |
| Mar 31, 2018 | -52.03% |
| Dec 31, 2017 | -29.96% |
| Sep 30, 2017 | -21.64% |
| Jun 30, 2017 | -15.18% |
| Mar 31, 2017 | -17.79% |
| Dec 31, 2016 | -29.75% |
| Sep 30, 2016 | -38.21% |
| Jun 30, 2016 | -43.31% |
| Mar 31, 2016 | -24.65% |
| Dec 31, 2015 | -22.68% |
| Sep 30, 2015 | -20.28% |